Glenn Oclassen Net Worth & Insider Trades

Glenn Oclassen - President and CEO, Transcept Pharmaceuticals Inc

As of October 30, 2014

What is Glenn Oclassen's Net Worth?

The current estimated net worth of Transcept Pharmaceuticals Inc's President and CEO, Glenn Oclassen, is estimated to be about $462.12K . Glenn Oclassen owns about 73,457 units of Transcept Pharmaceuticals Inc common stock. In the last 5 years at Transcept Pharmaceuticals Inc, Glenn Oclassen has sold an estimated value of $0 worth.

What is Glenn Oclassen's Past Insider Trading?

Glenn Oclassen's largest purchase order was 20,000 units , worth over $116K on September 20, 2011. In total, Glenn Oclassen has made about 14 transactions over 5 years of their time at Transcept Pharmaceuticals Inc. Glenn Oclassen usually trades in February and August, with the busiest year in 2011 and 2009.

GLENN OCLASSEN

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Glenn Oclassen's' Mailing Address?

  • Mailing address is 3290 West Bayshore Rd Palo Alto CA 94303 CA

What are Transcept Pharmaceuticals Inc's Past Insider Trades?

Transcept Pharmaceuticals Inc's most recent insider trade came on December 17, 2013 by Roumell Asset Management Llc who sold 1,470 units worth $5.2K . In the last 4 years, insiders at Transcept Pharmaceuticals Inc have sold an estimated value of $6.52M and bought an estimated value of $9.99M worth of shares. Insider trading is most common in February, with the busiest year in 2011. The most active traders at the company are Roumell Asset Management Llc,  Glenn Oclassen, President and CEO,  and Marilyn Wortzman, VP .

Transcept Pharmaceuticals Inc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1